The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Open accessAbstract
Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that OSKM induction activates the p53–p21 pathway25.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citationIn vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citationGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citationMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,003
Han, J., Mistriotis, P., Lei, P., Wang, D., Liu, S., & Andreadis, S. T. (2012) · Stem Cells · doi:10.1002/stem.1223 · Cited by 106
Higuchi, A., Ling, Q., Ko, Y.-A., Chang, Y., & Umezawa, A. (2011) · Chemical Reviews · doi:10.1021/cr1003612 · Cited by 105
Deng, Y., Zhou, Z., Ji, W., Lin, S., & Wang, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01814-4 · Cited by 106
Shen, Y., Lin, C., Chi, W.-H., Wang, C.-Y., Hsieh, Y.-T., Wei, Y., & Chen, Y.-J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/590393 · Cited by 103
Zhou, H., Xiao, J., Wu, N., Liu, C., Xu, J., Liu, F., & Wu, L. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.073 · Cited by 107
Function of oncogenes in cancer development: a changing paradigm
Vicente‐Dueñas, C., Romero-Camarero, I., Cobaleda, C., & Sánchez-Garcı́a, I. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.97 · Cited by 103
The paradigm of mutant p53-expressing cancer stem cells and drug resistance
Shetzer, Y., Solomon, H., Koifman, G., Molchadsky, A., Horesh, S., & Rotter, V. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu073 · Cited by 105
BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence
Hayashi, Y., Hsiao, E. C., Sami, S., Lancero, M., Schlieve, C. R., Nguyen, T., Yano, K., Nagahashi, A., Ikeya, M., Matsumoto, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603668113 · Cited by 105
Self-citationActivation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach
Plews, J. R., Li, J., Jones, M., Moore, H. D. M., Mason, C., Andrews, P. W., & Na, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014397 · Cited by 104
Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCsPreprint
Ungewitter, E. K., & Scrable, H. J. (2010) · Genes & Development · doi:10.1101/gad.1987810 · Cited by 101
Perspectives on cancer stem cells in osteosarcoma
Basu-Roy, U., Basilico, C., & Mansukhani, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.028 · Cited by 105
Kumar, M. R., Zhao, X., & Wang, X. W. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-5 · Cited by 103
Ye, D., Wang, G., Liu, Y., Huang, W., Wu, M., Zhu, S., Jia, W., Deng, A., Liu, H., & Kang, J. (2012) · Stem Cells · doi:10.1002/stem.1149 · Cited by 99
Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency
Son, M. J., Kwon, Y., Son, M.-Y., Seol, B., Choi, H.-S., Ryu, S.-W., Choi, C., & Cho, Y. S. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.43 · Cited by 99
The EMT spectrum and therapeutic opportunities
Voon, D. C., Huang, R. Y., Jackson, R. A., & Thiery, J. P. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12082 · Cited by 99
Induced pluripotent stem cells and reprogramming: seeing the science through the hype
Belmonte, J. C. I., Ellis, J., Hochedlinger, K., & Yamanaka, S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2700 · Cited by 98
Self-citationVázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martı́n-Castillo, B., López-Otı́n, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 98
MicroRNAs and Cardiac Regeneration
Hodgkinson, C. P., Kang, M. H., Dal-Pra, S., Mirotsou, M., & Dzau, V. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.304377 · Cited by 99
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症：英文版 · doi:10.1002/cac2.12520 · Cited by 103
miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2
Pfaff, N., Fiedler, J., Holzmann, A., Schambach, A., Moritz, T., Cantz, T., & Thum, T. (2011) · EMBO Reports · doi:10.1038/embor.2011.176 · Cited by 96
Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53
Takenaka, C., Nishishita, N., Takada, N., Jakt, L. M., & Kawamata, S. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.11.003 · Cited by 96
Huang, H., Chen, P.-H., Yu, C., Chuang, C.-Y., Stone, L., Hsiao, W.-C., Li, C.-L., Tsai, S.-C., Chen, K., Chen, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256164 · Cited by 96
Brouwer, M., Zhou, H., & Kasri, N. N. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9622-8 · Cited by 102
Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
Katz, S., Lechel, A., Obenauf, A. C., Begus‐Nahrmann, Y., Kraus, J. M., Hoffmann, E. M., Duda, J., Eshraghi, P., Hartmann, D., Liss, B., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.009 · Cited by 96
Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells
Álvarez, C. V., García-Lavandeira, M., Garcia-Rendueles, M. E. R., Díaz‐Rodriguez, E., Garcia-Rendueles, Á. R., Pérez-Romero, S., Vila, T. V., Rodrigues, J. S., Lear, P., & Bravo, S. B. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0072 · Cited by 97
Voon, D. C., Wang, H., Koo, J. K. W., Nguyen, T. A. P., Hor, Y. T., Chu, Y., Ito, K., Fukamachi, H., Chan, S. L., Thiery, J. P., et al. (2012) · Stem Cells · doi:10.1002/stem.1183 · Cited by 93
The role of DNA repair in the pluripotency and differentiation of human stem cells
Rocha, C. R. R., Lerner, L. K., Okamoto, O. K., Marchetto, M. C., & Menck, C. F. M. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.09.001 · Cited by 94
Energy metabolism plasticity enables stemness programs
Folmes, C. D. L., Nelson, T. J., Dzeja, P. P., & Terzic, A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06487.x · Cited by 94
LIF-Dependent Signaling: New Pieces in the Lego
Mathieu, M.-E., Saucourt, C., Mournetas, V., Gauthereau, X., Thézé, N., Praloran, V., Thiébaud, P., & Bœuf, H. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9261-7 · Cited by 96
The p53 tumor suppressor protein regulates hematopoietic stem cell fate
Asai, T., Liu, Y., Bae, N., & Nimer, S. D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22561 · Cited by 102
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
Lee, M. R., Prasain, N., Chae, H., Kim, Y., Mantel, C., Yöder, M. C., & Broxmeyer, H. E. (2012) · Stem Cells · doi:10.1002/stem.1302 · Cited by 90
Li, Z., & Rana, T. M. (2012) · Nature Communications · doi:10.1038/ncomms2059 · Cited by 89
Yew, T., Chiu, F., Tsai, C., Chen, H., Lee, W., Chen, Y., Chang, M.-C., & Hung, S. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00676.x · Cited by 90
Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming
Tan, L., Ke, Z., Tombline, G., Macoretta, N., Hayes, K., Tian, X., Lv, R., Ablaeva, J., Gilbert, M., Bhanu, N. V., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.001 · Cited by 88
Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming
Qin, H., Blaschke, K., Wei, G., Ohi, Y., Blouin, L., Qi, Z., Yu, J., Yeh, R., Hebrok, M., & Ramalho‐Santos, M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds023 · Cited by 92
Ohmine, S., Squillace, K. A., Hartjes, K. A., Deeds, M. C., Armstrong, A. S., Thatava, T., Sakuma, T., Terzic, A., Kudva, Y. C., & Ikeda, Y. (2012) · Aging · doi:10.18632/aging.100428 · Cited by 89
Love, I. M., Šekaric, P., Shi, D., Grossman, S. R., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.20864 · Cited by 89
Reprogramming of mouse and human somatic cells by high‐performance engineered factors
Wang, Y., Chen, J., Hu, J., Wei, X., Qin, D., Gao, J., Zhang, L., Jiang, J., Li, J., Liu, J., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.11 · Cited by 87
Yilmaz, A., & Benvenisty, N. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.06.010 · Cited by 91
Tissue engineering and the use of stem/progenitor cells for airway epithelium repair.
Roomans, G. (2010) · European Cells & Materials · doi:10.22203/ecm.v019a27 · Cited by 82
Kudva, Y. C., Ohmine, S., Greder, L. V., Dutton, J. R., Armstrong, A. S., Lamo, J. G. D., Khan, Y. K., Thatava, T., Hasegawa, M., Fusaki, N., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0044 · Cited by 87
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex
Pavan Kumar, P., Emechebe, U., Smith, R. A., Franklin, S., Moore, B., Yandell, M. D., Lessnick, S. L., & Moon, A. (2014) · eLife · doi:10.7554/elife.02805 · Cited by 87
Quantifying the Landscape for Development and Cancer from a Core Cancer Stem Cell Circuit
Li, C., & Wang, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0079 · Cited by 85
Multiple Roles of p53-Related Pathways in Somatic Cell Reprogramming and Stem Cell Differentiation
Yi, L., Lu, C.-W., Hu, W., Sun, Y., & Levine, A. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1451 · Cited by 87
Solozobova, V. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 87
Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors
Oshima, N., Yamada, Y., Nagayama, S., Kawada, K., Hasegawa, S., Okabe, H., Sakai, Y., & Aoi, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101735 · Cited by 84
Self-citationEbrahimi, B. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0024-9 · Cited by 87
Antioxidant Supplementation Reduces Genomic Aberrations in Human Induced Pluripotent Stem Cells
Ji, J., Sharma, V., Qi, S., Guarch, M. E., Zhao, P., Luo, Z., Fan, W., Wang, Y., Mbabaali, F., Neculai, D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.004 · Cited by 85
Edel, M. J., Menchón, C., Ménendez, S., Consiglio, A., Izpisúa Belmonte, J. C., & Belmonte, J. C. I. (2010) · Genes & Development · doi:10.1101/gad.1876710 · Cited by 84
Targeting p53-MDM2-MDMX Loop for Cancer Therapy
Zhang, Q., Zeng, S. X., & Lu, H. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_16 · Cited by 85
Liu, S., Zhang, Q., Shy, A. N., Yi, M., He, H., Lu, S., & Xu, B. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07923 · Cited by 83
The Promise of Stem Cell Research in Pigs and Other Ungulate Species
Telugu, B. P. V. L., Ezashi, T., & Roberts, R. M. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9101-1 · Cited by 83
MYC Activates Stem-like Cell Potential in Hepatocarcinoma by a p53-Dependent Mechanism
Akita, H., Marquardt, J. U., Durkin, M. E., Kitade, M., Seo, D., Conner, E. A., Andersen, J. B., Factor, V. M., & Thorgeirsson, S. S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0527 · Cited by 84
Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome
Andrade, L. N. D. S., Nathanson, J. L., Yeo, G. W.-M., Menck, C. F. M., & Muotri, A. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds211 · Cited by 83
Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers
Oikawa, T. (2016) · Hepatology · doi:10.1002/hep.28485 · Cited by 84
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Xie, X., Piao, L., Bullock, B. N., Smith, A., Su, T., Zhang, M., Teknos, T. N., Arora, P. S., & Pan, Q. (2013) · Oncogene · doi:10.1038/onc.2013.25 · Cited by 80
Clinical Outcomes of TP53 Mutations in CancersPreprint
Robles, A. I., Jen, J., & Harris, C. C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026294 · Cited by 86
Reprogramming of Postnatal Neurons into Induced Pluripotent Stem Cells by Defined Factors
Kim, J., Lengner, C. J., Kirak, O., Hanna, J. H., Cassady, J. P., Lodato, M. A., Wu, S., Faddah, D. A., Steine, E. J., Gao, Q., et al. (2011) · Stem Cells · doi:10.1002/stem.641 · Cited by 83
He, C., Li, L., Guan, X., Li, X., & Miao, X. (2016) · Chemotherapy · doi:10.1159/000446361 · Cited by 80
Expanding the p53 regulatory network: LncRNAs take up the challenge
Grossi, E., Sánchez, Y., & Huarte, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.011 · Cited by 78
Satō, A., Okada, M., Shibuya, K., Watanabe, E., Seino, S., Suzuki, K., Narita, Y., Shibui, S., Kayama, T., & Kitanaka, C. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.04.004 · Cited by 78
Hematopoietic stem cell engineering at a crossroads
Rivière, I., Dunbar, C. E., & Sadelain, M. (2011) · Blood · doi:10.1182/blood-2011-09-349993 · Cited by 80
Selvaraj, V., Plane, J. M., Williams, A. J., & Deng, W. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.01.002 · Cited by 83
microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming
Li, M. A., & He, L. (2012) · BioEssays · doi:10.1002/bies.201200019 · Cited by 77
Sone, M., Morone, N., Nakamura, T., Tanaka, A., Okita, K., Woltjen, K., Nakagawa, M., Heuser, J. E., Yamada, Y., Yamanaka, S., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.017 · Cited by 77
Self-citationDifferential contribution of p300 and CBP to regulatory element acetylation in mESCs
Martire, S., Nguyen, J., Sundaresan, A., & Banaszynski, L. A. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00296-9 · Cited by 82
DNA double‐strand break response in stem cells: Mechanisms to maintain genomic integrity
Nagaria, P. K., Robert, C., & Rassool, F. V. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.001 · Cited by 78
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Zhou, X. Y., Hao, Q., Liao, P., Luo, S., Zhang, M., Hu, G., Liu, H., Zhang, Y.-W., Cao, B., Baddoo, M., et al. (2016) · eLife · doi:10.7554/elife.15099 · Cited by 84
A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells
Wang, Y., Mah, N., Prigione, A., Wolfrum, K., Andrade-Navarro, M. A., & Adjaye, J. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9137-2 · Cited by 76
Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation
Masip, M., Veiga, A., Belmonte, J. C. I., & Simón, C. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq059 · Cited by 76
The long and winding road of reprogramming-induced rejuvenation
Yücel, A. D., & Gladyshev, V. N. (2024) · Nature Communications · doi:10.1038/s41467-024-46020-5 · Cited by 85
Fukushima, H., Ogura, K., Wan, L., Lu, Y., Li, V. C., Gao, D., Liu, P., Lau, A. W., Wu, T., Kirschner, M. W., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.031 · Cited by 76
Identification of Oct4-activating compounds that enhance reprogramming efficiency
Li, W., Tian, E., Chen, Z., Sun, G., Peng, Y., Yang, S. J., Lu, D., Xie, J., Ho, T., Tsark, W. M. K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219181110 · Cited by 79
Horikawa, I., Park, K., Isogaya, K., Hiyoshi, Y., Li, H., Anami, K., Robles, A. I., Mondal, A. M., Fujita, K., Serrano, M., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.48 · Cited by 76
Reprogramming with Small Molecules instead of Exogenous Transcription Factors
Lin, T., & Wu, S. (2015) · Stem Cells International · doi:10.1155/2015/794632 · Cited by 78
Cancer Stemness: p53 at the Wheel
Ghatak, D., Ghosh, D. D., & Roychoudhury, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604124 · Cited by 75
Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 66
Saito, S., Lin, Y., Tsai, M., Lin, C., Murayama, Y., Sato, R., & Yokoyama, K. K. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.03.002 · Cited by 76
MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs
Lu, D., Davis, M. P. A., Abreu‐Goodger, C., Wang, W., Campos, L. S., Siede, J., Vigorito, E., Skarnes, W. C., Dunham, I., Enright, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040938 · Cited by 74
Induced pluripotent stem cells: A new era for hepatology
Asgari, S., Pournasr, B., Salekdeh, G. H., Ghodsizadeh, A., Ott, M., & Baharvand, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.009 · Cited by 75
Metabolism in pluripotency: Both driver and passenger?
Dahan, P., Lu, V., Nguyen, R., Kennedy, S. A. L., & Teitell, M. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000832 · Cited by 74
Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity
Lin, S., Chou, Y., Jiang, S. S., Chang, J.-L., Chung, C.-H., Kao, Y.-R., Chang, I., & Wu, C.-W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3178 · Cited by 73
Concise Review: Immune Recognition of Induced Pluripotent Stem Cells
Boyd, A. S., Rodrigues, N. P., Lui, K. O., Fu, X., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1066 · Cited by 76
Kramer, A. S., Harvey, A. R., Plant, G. W., & Hodgetts, S. I. (2012) · Cell Transplantation · doi:10.3727/096368912x655208 · Cited by 73
Notch inhibition allows oncogene-independent generation of iPS cells
Ichida, J. K., Julia, T. C. W., Williams, L. A., Carter, A. C., Shi, Y., Moura, M. T., Ziller, M. J., Singh, S., Amabile, G., Bock, C., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1552 · Cited by 75
Trokovic, R., Weltner, J., Noisa, P., Raivio, T., & Otonkoski, T. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.06.001 · Cited by 74
Hamard, P.-J., Barthelery, N. J., Hogstad, B., Mungamuri, S. K., Tonnessen-Murray, C. A., Carvajal, L. A., Senturk, E., Gillespie, V., Aaronson, S. A., Mérad, M., et al. (2013) · Genes & Development · doi:10.1101/gad.224386.113 · Cited by 79
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
Hiratsuka, M., Uno, N., Ueda, K., Kurosaki, H., Imaoka, N., Kazuki, K., Ueno, E., Akakura, Y., Katoh, M., Osaki, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025961 · Cited by 70
Self-citationA model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Hruška-Plocháň, M., Wiersma, V. I., Betz, K. M., Mallona, I., Ronchi, S., Maniecka, Z., Hock, E., Tantardini, E., Laferrière, F., Sahadevan, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07042-7 · Cited by 73
The emerging role of p53 in stem cells
Bonizzi, G., Cicalese, A., Insinga, A., & Pelicci, P. G. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.002 · Cited by 74
p53-Facilitated miR-199a-3p Regulates Somatic Cell Reprogramming
Wang, J., He, Q., Han, C., Gu, H., Jin, L., Li, Q., Mei, Y., & Wu, M. (2012) · Stem Cells · doi:10.1002/stem.1121 · Cited by 72
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 74
Tao, L., Roberts, A. L., Dunphy, K. A., Bigelow, C., Yan, H., & Jerry, D. J. (2010) · Stem Cells · doi:10.1002/stem.552 · Cited by 75
p53 connects tumorigenesis and reprogramming to pluripotency
Tàpia, N., & Schöler, H. R. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101866 · Cited by 71
Integrating Physiological Regulation with Stem Cell and Tissue Homeostasis
Nakada, D., Levi, B. P., & Morrison, S. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.011 · Cited by 78
Two Factor Reprogramming of Human Neural Stem Cells into Pluripotency
Hester, M. E., Song, S., Miranda, C. J., Eagle, A., Schwartz, P. H., & Kaspar, B. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007044 · Cited by 70
Direct Generation of Induced Pluripotent Stem Cells from Human Nonmobilized Blood
Kunisato, A., Wakatsuki, M., Shinba, H., Ota, T., Ishida, I., & Nagao, K. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0063 · Cited by 70
High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes
Ruiz, S., Brennand, K., Panopoulos, A. D., Herrerias, A., Gage, F. H., & Izpisúa‐Belmonte, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015526 · Cited by 70
Metadata
- Authors
- Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Gladstone Institutes (US)
- Corresponding author
- Yamanaka, Shinya
- Venue
- Nature
- Published
- 2009-08
- Volume
- 460
- Issue
- 7259
- Pages
- 1132-1135
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2917235
- OpenAlex
- W2081620485
- Cited by
- 1,301
- References
- 23
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
- FWCI
- 67.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL100406)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
- MeSH terms
- Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
